Lyvispah
Product Images NDC 70257-416

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lyvispah (NDC 70257-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Saol Therapeutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Lyvispah 1)

Chemical structure diagram showing the molecular formula of the active ingredient associated with Lyvispah. The structure includes a chlorophenyl group attached to a carbon bearing both an aminomethyl and a carboxymethyl group.*

FDA Label Image

Packet-image (Lyvispah 2)

The image shows a section of a Lyvispah (baclofen) oral granules package label. The label includes instructions to "Use Scissors" along a perforated line for opening. The label displays the Lyvispah name with the active ingredient baclofen noted, indicating this is the container for oral granules. The labeler is Saol Therapeutics Inc.*

FDA Label Image

5mg Carton (Lyvispah 3)

Lyvispah 5 mg oral granules packaging label from Saol Therapeutics Inc. This carton contains 90 individual packets of 5 mg baclofen oral granules. The label includes directions for use, storage instructions (20°C to 25°C), and warnings about keeping the drug out of reach of children. The design features a green and white color scheme with purple accents and legal cautions about drug transfer restrictions.*

FDA Label Image

5mg Container (Lyvispah 4)

Packaging label of Lyvispah 5 mg (baclofen) oral granules. The label states it is distributed by Saol Therapeutics, Inc. It includes storage instructions for controlled room temperature and mentions the package is child-resistant. The label also highlights that each packet contains 5 mg baclofen and includes placeholders for lot and expiration dates.*

FDA Label Image

10mg Carton (Lyvispah 5)

Packaging label for Lyvispah 10 mg oral granules (baclofen) by Saol Therapeutics Inc. The carton indicates 90 individual packets for oral administration with detailed directions for use, dosage instructions, storage conditions, and cautionary statements. The label includes a barcode and NDC 70257-414-87.*

FDA Label Image

10mg Container (Lyvispah 6)

Label for Lyvispah 10 mg oral granules containing baclofen, distributed by Saol Therapeutics Inc. The label includes storage instructions, stating the product is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The label also indicates the lot and expiration date fields.*

FDA Label Image

20mg Carton (Lyvispah 7)

The packaging label for Lyvispah 20 mg oral granules by Saol Therapeutics Inc. The label displays the proprietary name, active ingredient baclofen 20 mg per packet, and states each box contains 90 individual packets. Directions for use and storage instructions are included, along with a caution about drug transfer restrictions. The label features orange and purple color blocks with a barcode and manufacturer information.*

FDA Label Image

20mg Container (Lyvispah 8)

Label for Lyvispah 20 mg (baclofen) oral granules, distributed by Saol Therapeutics Inc. The label includes storage instructions, noting the package is child-resistant and should be stored between 20°C to 25°C with permitted excursions from 15°C to 30°C. It also directs users to see the package insert for full prescribing information. The label indicates the product is Rx only and includes placeholders for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.